top of page
Olesja Bondarenko, PhD
CEO
Olesja has extensive international experience in research and development, along with a proven track record in building and leading global teams. Before co-founding Nanordica Medical, she was a PI of the scientific group at the National Institute of Chemical Physics and Biophysics studying nanoparticle safety and antimicrobial properties. She published over 30 peer-reviewed publications and served as a postdoctoral researcher in the world-class teams at Karolinska Institute (Sweden) and the University of Helsinki (Finland), where her work focused on the applications of nanoparticles in medicine and their interactions with human cells.
bottom of page